nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2A6—Fluorouracil—colon cancer	0.264	0.371	CbGbCtD
Tranylcypromine—CYP2C9—Capecitabine—colon cancer	0.153	0.215	CbGbCtD
Tranylcypromine—CYP1A2—Fluorouracil—colon cancer	0.101	0.142	CbGbCtD
Tranylcypromine—CYP2C9—Fluorouracil—colon cancer	0.0908	0.128	CbGbCtD
Tranylcypromine—CYP3A4—Irinotecan—colon cancer	0.055	0.0773	CbGbCtD
Tranylcypromine—CYP3A4—Vincristine—colon cancer	0.0481	0.0675	CbGbCtD
Tranylcypromine—Memory loss—Fluorouracil—colon cancer	0.0123	0.0429	CcSEcCtD
Tranylcypromine—Hypertensive crisis—Capecitabine—colon cancer	0.00914	0.0317	CcSEcCtD
Tranylcypromine—Inappropriate antidiuretic hormone secretion—Vincristine—colon cancer	0.0067	0.0232	CcSEcCtD
Tranylcypromine—Myoclonus—Vincristine—colon cancer	0.00647	0.0224	CcSEcCtD
Tranylcypromine—Numbness—Vincristine—colon cancer	0.00469	0.0163	CcSEcCtD
Tranylcypromine—Sensory loss—Vincristine—colon cancer	0.00449	0.0156	CcSEcCtD
Tranylcypromine—Numbness—Fluorouracil—colon cancer	0.00438	0.0152	CcSEcCtD
Tranylcypromine—Myoclonus—Capecitabine—colon cancer	0.00422	0.0146	CcSEcCtD
Tranylcypromine—Sensory loss—Fluorouracil—colon cancer	0.00419	0.0145	CcSEcCtD
Tranylcypromine—Tenderness—Fluorouracil—colon cancer	0.00416	0.0144	CcSEcCtD
Tranylcypromine—Neck stiffness—Methotrexate—colon cancer	0.00397	0.0138	CcSEcCtD
Tranylcypromine—Nuchal rigidity—Methotrexate—colon cancer	0.00364	0.0126	CcSEcCtD
Tranylcypromine—Disorientation—Fluorouracil—colon cancer	0.00295	0.0102	CcSEcCtD
Tranylcypromine—Musculoskeletal stiffness—Capecitabine—colon cancer	0.00283	0.00981	CcSEcCtD
Tranylcypromine—Amnesia—Fluorouracil—colon cancer	0.0028	0.00973	CcSEcCtD
Tranylcypromine—Urinary retention—Vincristine—colon cancer	0.00269	0.00932	CcSEcCtD
Tranylcypromine—Ataxia—Vincristine—colon cancer	0.00266	0.00922	CcSEcCtD
Tranylcypromine—Blood pressure increased—Capecitabine—colon cancer	0.00254	0.0088	CcSEcCtD
Tranylcypromine—Ataxia—Fluorouracil—colon cancer	0.00248	0.0086	CcSEcCtD
Tranylcypromine—Urinary incontinence—Capecitabine—colon cancer	0.00245	0.0085	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Vincristine—colon cancer	0.00225	0.0078	CcSEcCtD
Tranylcypromine—Musculoskeletal stiffness—Methotrexate—colon cancer	0.0021	0.0073	CcSEcCtD
Tranylcypromine—Sweating—Vincristine—colon cancer	0.00209	0.00724	CcSEcCtD
Tranylcypromine—Sweating—Irinotecan—colon cancer	0.00203	0.00705	CcSEcCtD
Tranylcypromine—Amnesia—Capecitabine—colon cancer	0.00196	0.0068	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Vincristine—colon cancer	0.00194	0.00675	CcSEcCtD
Tranylcypromine—Bradycardia—Irinotecan—colon cancer	0.00194	0.00672	CcSEcCtD
Tranylcypromine—Haemoglobin—Irinotecan—colon cancer	0.00191	0.00664	CcSEcCtD
Tranylcypromine—Haemorrhage—Irinotecan—colon cancer	0.0019	0.0066	CcSEcCtD
Tranylcypromine—Agranulocytosis—Fluorouracil—colon cancer	0.00189	0.00658	CcSEcCtD
Tranylcypromine—Haemoglobin—Fluorouracil—colon cancer	0.00183	0.00636	CcSEcCtD
Tranylcypromine—Haemorrhage—Fluorouracil—colon cancer	0.00182	0.00633	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Fluorouracil—colon cancer	0.00181	0.00629	CcSEcCtD
Tranylcypromine—Flushing—Irinotecan—colon cancer	0.00177	0.00613	CcSEcCtD
Tranylcypromine—Urinary retention—Capecitabine—colon cancer	0.00175	0.00608	CcSEcCtD
Tranylcypromine—Ataxia—Capecitabine—colon cancer	0.00173	0.00601	CcSEcCtD
Tranylcypromine—Alopecia—Vincristine—colon cancer	0.00173	0.00599	CcSEcCtD
Tranylcypromine—Chills—Irinotecan—colon cancer	0.00171	0.00593	CcSEcCtD
Tranylcypromine—Alopecia—Irinotecan—colon cancer	0.00168	0.00584	CcSEcCtD
Tranylcypromine—Alopecia—Fluorouracil—colon cancer	0.00161	0.00559	CcSEcCtD
Tranylcypromine—Muscle spasms—Irinotecan—colon cancer	0.00159	0.00553	CcSEcCtD
Tranylcypromine—Anaemia—Vincristine—colon cancer	0.00157	0.00546	CcSEcCtD
Tranylcypromine—Agitation—Vincristine—colon cancer	0.00156	0.00543	CcSEcCtD
Tranylcypromine—Anaemia—Irinotecan—colon cancer	0.00153	0.00531	CcSEcCtD
Tranylcypromine—Leukopenia—Vincristine—colon cancer	0.00152	0.00528	CcSEcCtD
Tranylcypromine—Vision blurred—Fluorouracil—colon cancer	0.0015	0.00519	CcSEcCtD
Tranylcypromine—Syncope—Irinotecan—colon cancer	0.00149	0.00516	CcSEcCtD
Tranylcypromine—Leukopenia—Irinotecan—colon cancer	0.00148	0.00515	CcSEcCtD
Tranylcypromine—Hypertension—Vincristine—colon cancer	0.00147	0.0051	CcSEcCtD
Tranylcypromine—Anaemia—Fluorouracil—colon cancer	0.00147	0.00509	CcSEcCtD
Tranylcypromine—Loss of consciousness—Irinotecan—colon cancer	0.00146	0.00505	CcSEcCtD
Tranylcypromine—Hypertension—Irinotecan—colon cancer	0.00143	0.00496	CcSEcCtD
Tranylcypromine—Leukopenia—Fluorouracil—colon cancer	0.00142	0.00493	CcSEcCtD
Tranylcypromine—Oedema—Vincristine—colon cancer	0.00139	0.00482	CcSEcCtD
Tranylcypromine—Confusional state—Irinotecan—colon cancer	0.00136	0.00473	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Vincristine—colon cancer	0.00136	0.00472	CcSEcCtD
Tranylcypromine—Oedema—Irinotecan—colon cancer	0.00135	0.00469	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Vincristine—colon cancer	0.00134	0.00466	CcSEcCtD
Tranylcypromine—Shock—Irinotecan—colon cancer	0.00133	0.00462	CcSEcCtD
Tranylcypromine—Agranulocytosis—Capecitabine—colon cancer	0.00132	0.0046	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Irinotecan—colon cancer	0.00132	0.00459	CcSEcCtD
Tranylcypromine—Anorexia—Vincristine—colon cancer	0.00132	0.00459	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Irinotecan—colon cancer	0.00131	0.00454	CcSEcCtD
Tranylcypromine—Confusional state—Fluorouracil—colon cancer	0.00131	0.00453	CcSEcCtD
Tranylcypromine—Hypotension—Vincristine—colon cancer	0.0013	0.0045	CcSEcCtD
Tranylcypromine—Bradycardia—Capecitabine—colon cancer	0.0013	0.0045	CcSEcCtD
Tranylcypromine—Oedema—Fluorouracil—colon cancer	0.00129	0.00449	CcSEcCtD
Tranylcypromine—Anorexia—Irinotecan—colon cancer	0.00129	0.00447	CcSEcCtD
Tranylcypromine—Ataxia—Methotrexate—colon cancer	0.00129	0.00447	CcSEcCtD
Tranylcypromine—Haemoglobin—Capecitabine—colon cancer	0.00128	0.00444	CcSEcCtD
Tranylcypromine—Hepatitis—Capecitabine—colon cancer	0.00127	0.00442	CcSEcCtD
Tranylcypromine—Haemorrhage—Capecitabine—colon cancer	0.00127	0.00442	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Fluorouracil—colon cancer	0.00127	0.0044	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Capecitabine—colon cancer	0.00127	0.0044	CcSEcCtD
Tranylcypromine—Tachycardia—Fluorouracil—colon cancer	0.00126	0.00439	CcSEcCtD
Tranylcypromine—Hypotension—Irinotecan—colon cancer	0.00126	0.00438	CcSEcCtD
Tranylcypromine—Insomnia—Vincristine—colon cancer	0.00126	0.00436	CcSEcCtD
Tranylcypromine—Paraesthesia—Vincristine—colon cancer	0.00125	0.00433	CcSEcCtD
Tranylcypromine—Anorexia—Fluorouracil—colon cancer	0.00123	0.00428	CcSEcCtD
Tranylcypromine—Insomnia—Irinotecan—colon cancer	0.00122	0.00424	CcSEcCtD
Tranylcypromine—Paraesthesia—Irinotecan—colon cancer	0.00121	0.00421	CcSEcCtD
Tranylcypromine—Hypotension—Fluorouracil—colon cancer	0.00121	0.0042	CcSEcCtD
Tranylcypromine—Decreased appetite—Vincristine—colon cancer	0.00121	0.00419	CcSEcCtD
Tranylcypromine—Somnolence—Irinotecan—colon cancer	0.0012	0.00417	CcSEcCtD
Tranylcypromine—Tinnitus—Capecitabine—colon cancer	0.00119	0.00412	CcSEcCtD
Tranylcypromine—Pain—Vincristine—colon cancer	0.00119	0.00412	CcSEcCtD
Tranylcypromine—Constipation—Vincristine—colon cancer	0.00119	0.00412	CcSEcCtD
Tranylcypromine—Flushing—Capecitabine—colon cancer	0.00118	0.0041	CcSEcCtD
Tranylcypromine—Decreased appetite—Irinotecan—colon cancer	0.00118	0.00408	CcSEcCtD
Tranylcypromine—Insomnia—Fluorouracil—colon cancer	0.00117	0.00406	CcSEcCtD
Tranylcypromine—Paraesthesia—Fluorouracil—colon cancer	0.00116	0.00404	CcSEcCtD
Tranylcypromine—Pain—Irinotecan—colon cancer	0.00116	0.00401	CcSEcCtD
Tranylcypromine—Constipation—Irinotecan—colon cancer	0.00116	0.00401	CcSEcCtD
Tranylcypromine—Somnolence—Fluorouracil—colon cancer	0.00115	0.004	CcSEcCtD
Tranylcypromine—Chills—Capecitabine—colon cancer	0.00114	0.00397	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Vincristine—colon cancer	0.00114	0.00394	CcSEcCtD
Tranylcypromine—Decreased appetite—Fluorouracil—colon cancer	0.00113	0.00391	CcSEcCtD
Tranylcypromine—Alopecia—Capecitabine—colon cancer	0.00113	0.00391	CcSEcCtD
Tranylcypromine—Feeling abnormal—Irinotecan—colon cancer	0.00111	0.00387	CcSEcCtD
Tranylcypromine—Pain—Fluorouracil—colon cancer	0.00111	0.00384	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Irinotecan—colon cancer	0.00111	0.00384	CcSEcCtD
Tranylcypromine—Abdominal pain—Vincristine—colon cancer	0.0011	0.00381	CcSEcCtD
Tranylcypromine—Body temperature increased—Vincristine—colon cancer	0.0011	0.00381	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Methotrexate—colon cancer	0.00109	0.00379	CcSEcCtD
Tranylcypromine—Abdominal pain—Irinotecan—colon cancer	0.00107	0.00371	CcSEcCtD
Tranylcypromine—Body temperature increased—Irinotecan—colon cancer	0.00107	0.00371	CcSEcCtD
Tranylcypromine—Feeling abnormal—Fluorouracil—colon cancer	0.00107	0.0037	CcSEcCtD
Tranylcypromine—Muscle spasms—Capecitabine—colon cancer	0.00107	0.0037	CcSEcCtD
Tranylcypromine—Drowsiness—Methotrexate—colon cancer	0.00106	0.00367	CcSEcCtD
Tranylcypromine—Vision blurred—Capecitabine—colon cancer	0.00104	0.00363	CcSEcCtD
Tranylcypromine—Tremor—Capecitabine—colon cancer	0.00104	0.00361	CcSEcCtD
Tranylcypromine—Urticaria—Fluorouracil—colon cancer	0.00103	0.00357	CcSEcCtD
Tranylcypromine—Anaemia—Capecitabine—colon cancer	0.00102	0.00356	CcSEcCtD
Tranylcypromine—Body temperature increased—Fluorouracil—colon cancer	0.00102	0.00355	CcSEcCtD
Tranylcypromine—Sweating—Methotrexate—colon cancer	0.00101	0.00351	CcSEcCtD
Tranylcypromine—Asthenia—Vincristine—colon cancer	0.000996	0.00346	CcSEcCtD
Tranylcypromine—Syncope—Capecitabine—colon cancer	0.000994	0.00345	CcSEcCtD
Tranylcypromine—Leukopenia—Capecitabine—colon cancer	0.000993	0.00344	CcSEcCtD
Tranylcypromine—Agranulocytosis—Methotrexate—colon cancer	0.000986	0.00342	CcSEcCtD
Tranylcypromine—Palpitations—Capecitabine—colon cancer	0.00098	0.0034	CcSEcCtD
Tranylcypromine—Loss of consciousness—Capecitabine—colon cancer	0.000975	0.00338	CcSEcCtD
Tranylcypromine—Asthenia—Irinotecan—colon cancer	0.00097	0.00337	CcSEcCtD
Tranylcypromine—Hypertension—Capecitabine—colon cancer	0.000957	0.00332	CcSEcCtD
Tranylcypromine—Haemoglobin—Methotrexate—colon cancer	0.000953	0.00331	CcSEcCtD
Tranylcypromine—Diarrhoea—Vincristine—colon cancer	0.00095	0.0033	CcSEcCtD
Tranylcypromine—Haemorrhage—Methotrexate—colon cancer	0.000948	0.00329	CcSEcCtD
Tranylcypromine—Hepatitis—Methotrexate—colon cancer	0.000948	0.00329	CcSEcCtD
Tranylcypromine—Anxiety—Capecitabine—colon cancer	0.000941	0.00326	CcSEcCtD
Tranylcypromine—Diarrhoea—Irinotecan—colon cancer	0.000925	0.00321	CcSEcCtD
Tranylcypromine—Dry mouth—Capecitabine—colon cancer	0.000923	0.0032	CcSEcCtD
Tranylcypromine—Dizziness—Vincristine—colon cancer	0.000918	0.00319	CcSEcCtD
Tranylcypromine—Confusional state—Capecitabine—colon cancer	0.000912	0.00317	CcSEcCtD
Tranylcypromine—Oedema—Capecitabine—colon cancer	0.000905	0.00314	CcSEcCtD
Tranylcypromine—Dizziness—Irinotecan—colon cancer	0.000894	0.0031	CcSEcCtD
Tranylcypromine—Shock—Capecitabine—colon cancer	0.00089	0.00309	CcSEcCtD
Tranylcypromine—Diarrhoea—Fluorouracil—colon cancer	0.000886	0.00307	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Capecitabine—colon cancer	0.000886	0.00307	CcSEcCtD
Tranylcypromine—Tinnitus—Methotrexate—colon cancer	0.000884	0.00307	CcSEcCtD
Tranylcypromine—Tachycardia—Capecitabine—colon cancer	0.000883	0.00307	CcSEcCtD
Tranylcypromine—Vomiting—Vincristine—colon cancer	0.000883	0.00306	CcSEcCtD
Tranylcypromine—Rash—Vincristine—colon cancer	0.000875	0.00304	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Capecitabine—colon cancer	0.000875	0.00304	CcSEcCtD
Tranylcypromine—Dermatitis—Vincristine—colon cancer	0.000875	0.00304	CcSEcCtD
Tranylcypromine—Headache—Vincristine—colon cancer	0.00087	0.00302	CcSEcCtD
Tranylcypromine—Anorexia—Capecitabine—colon cancer	0.000863	0.00299	CcSEcCtD
Tranylcypromine—Vomiting—Irinotecan—colon cancer	0.00086	0.00298	CcSEcCtD
Tranylcypromine—Dizziness—Fluorouracil—colon cancer	0.000856	0.00297	CcSEcCtD
Tranylcypromine—Rash—Irinotecan—colon cancer	0.000853	0.00296	CcSEcCtD
Tranylcypromine—Dermatitis—Irinotecan—colon cancer	0.000852	0.00296	CcSEcCtD
Tranylcypromine—Chills—Methotrexate—colon cancer	0.000851	0.00295	CcSEcCtD
Tranylcypromine—Headache—Irinotecan—colon cancer	0.000847	0.00294	CcSEcCtD
Tranylcypromine—Hypotension—Capecitabine—colon cancer	0.000846	0.00293	CcSEcCtD
Tranylcypromine—Alopecia—Methotrexate—colon cancer	0.000838	0.00291	CcSEcCtD
Tranylcypromine—Nausea—Vincristine—colon cancer	0.000825	0.00286	CcSEcCtD
Tranylcypromine—Vomiting—Fluorouracil—colon cancer	0.000823	0.00286	CcSEcCtD
Tranylcypromine—Insomnia—Capecitabine—colon cancer	0.000818	0.00284	CcSEcCtD
Tranylcypromine—Rash—Fluorouracil—colon cancer	0.000817	0.00283	CcSEcCtD
Tranylcypromine—Dermatitis—Fluorouracil—colon cancer	0.000816	0.00283	CcSEcCtD
Tranylcypromine—Paraesthesia—Capecitabine—colon cancer	0.000813	0.00282	CcSEcCtD
Tranylcypromine—Headache—Fluorouracil—colon cancer	0.000811	0.00282	CcSEcCtD
Tranylcypromine—Nausea—Irinotecan—colon cancer	0.000803	0.00279	CcSEcCtD
Tranylcypromine—Decreased appetite—Capecitabine—colon cancer	0.000787	0.00273	CcSEcCtD
Tranylcypromine—Vision blurred—Methotrexate—colon cancer	0.000778	0.0027	CcSEcCtD
Tranylcypromine—Pain—Capecitabine—colon cancer	0.000774	0.00269	CcSEcCtD
Tranylcypromine—Constipation—Capecitabine—colon cancer	0.000774	0.00269	CcSEcCtD
Tranylcypromine—Nausea—Fluorouracil—colon cancer	0.000769	0.00267	CcSEcCtD
Tranylcypromine—Anaemia—Methotrexate—colon cancer	0.000763	0.00265	CcSEcCtD
Tranylcypromine—Feeling abnormal—Capecitabine—colon cancer	0.000746	0.00259	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Capecitabine—colon cancer	0.00074	0.00257	CcSEcCtD
Tranylcypromine—Leukopenia—Methotrexate—colon cancer	0.000739	0.00256	CcSEcCtD
Tranylcypromine—Urticaria—Capecitabine—colon cancer	0.000719	0.00249	CcSEcCtD
Tranylcypromine—Body temperature increased—Capecitabine—colon cancer	0.000715	0.00248	CcSEcCtD
Tranylcypromine—Abdominal pain—Capecitabine—colon cancer	0.000715	0.00248	CcSEcCtD
Tranylcypromine—Confusional state—Methotrexate—colon cancer	0.000679	0.00236	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Methotrexate—colon cancer	0.00066	0.00229	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Methotrexate—colon cancer	0.000651	0.00226	CcSEcCtD
Tranylcypromine—Asthenia—Capecitabine—colon cancer	0.000649	0.00225	CcSEcCtD
Tranylcypromine—Anorexia—Methotrexate—colon cancer	0.000642	0.00223	CcSEcCtD
Tranylcypromine—Hypotension—Methotrexate—colon cancer	0.000629	0.00218	CcSEcCtD
Tranylcypromine—Diarrhoea—Capecitabine—colon cancer	0.000619	0.00215	CcSEcCtD
Tranylcypromine—Insomnia—Methotrexate—colon cancer	0.000609	0.00211	CcSEcCtD
Tranylcypromine—Paraesthesia—Methotrexate—colon cancer	0.000605	0.0021	CcSEcCtD
Tranylcypromine—Somnolence—Methotrexate—colon cancer	0.000599	0.00208	CcSEcCtD
Tranylcypromine—Dizziness—Capecitabine—colon cancer	0.000598	0.00208	CcSEcCtD
Tranylcypromine—Decreased appetite—Methotrexate—colon cancer	0.000586	0.00203	CcSEcCtD
Tranylcypromine—Pain—Methotrexate—colon cancer	0.000576	0.002	CcSEcCtD
Tranylcypromine—Vomiting—Capecitabine—colon cancer	0.000575	0.002	CcSEcCtD
Tranylcypromine—Rash—Capecitabine—colon cancer	0.000571	0.00198	CcSEcCtD
Tranylcypromine—Dermatitis—Capecitabine—colon cancer	0.00057	0.00198	CcSEcCtD
Tranylcypromine—Headache—Capecitabine—colon cancer	0.000567	0.00197	CcSEcCtD
Tranylcypromine—Feeling abnormal—Methotrexate—colon cancer	0.000555	0.00193	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Methotrexate—colon cancer	0.000551	0.00191	CcSEcCtD
Tranylcypromine—Nausea—Capecitabine—colon cancer	0.000538	0.00187	CcSEcCtD
Tranylcypromine—Urticaria—Methotrexate—colon cancer	0.000535	0.00186	CcSEcCtD
Tranylcypromine—Abdominal pain—Methotrexate—colon cancer	0.000533	0.00185	CcSEcCtD
Tranylcypromine—Body temperature increased—Methotrexate—colon cancer	0.000533	0.00185	CcSEcCtD
Tranylcypromine—Asthenia—Methotrexate—colon cancer	0.000483	0.00168	CcSEcCtD
Tranylcypromine—Diarrhoea—Methotrexate—colon cancer	0.000461	0.0016	CcSEcCtD
Tranylcypromine—Dizziness—Methotrexate—colon cancer	0.000445	0.00155	CcSEcCtD
Tranylcypromine—Vomiting—Methotrexate—colon cancer	0.000428	0.00149	CcSEcCtD
Tranylcypromine—Rash—Methotrexate—colon cancer	0.000425	0.00147	CcSEcCtD
Tranylcypromine—Dermatitis—Methotrexate—colon cancer	0.000424	0.00147	CcSEcCtD
Tranylcypromine—Headache—Methotrexate—colon cancer	0.000422	0.00146	CcSEcCtD
Tranylcypromine—Nausea—Methotrexate—colon cancer	0.0004	0.00139	CcSEcCtD
